Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaume Puig Junoy

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Pharmacoeconomics|June 3, 2010
Impact of European pharmaceutical price regulation on generic price competition: a reviewJaume Puig-Junoy
Health Policy (Amsterdam, Netherlands)|January 15, 2004
Incentives and pharmaceutical reimbursement reforms in SpainJaume Puig-Junoy
Gaceta Sanitaria|October 6, 2007
[Comment. Substitution at pharmacies and generic market]Jaume Puig-Junoy
Gaceta Sanitaria|February 20, 2007
[The financing and price regulation of drugs in the Spanish National Health System: changes and continuity]Jaume Puig-Junoy
Health Policy (Amsterdam, Netherlands)|March 21, 2007
The impact of generic reference pricing interventions in the statin marketJaume Puig-Junoy
Revista De Enfermeria (Barcelona, Spain)|September 16, 2004
[Treatment and capitation integration]Jaume Puig Junoy
Gaceta Sanitaria|March 17, 2006
[Health care financing: is it enough and appropriate?]Jaume Puig-Junoy
Gaceta Sanitaria|March 2, 2010
[Policies encouraging price competition in the generic drug market: Lessons from the European experience]Jaume Puig-Junoy
Applied Health Economics and Health Policy|August 21, 2012
Do higher-priced generic medicines enjoy a competitive advantage under reference pricing?Jaume Puig-Junoy
Applied Health Economics and Health Policy|September 16, 2005
What is required to evaluate the impact of pharmaceutical reference pricing?Jaume Puig-Junoy
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Pharmacoeconomics|June 3, 2010
Impact of European pharmaceutical price regulation on generic price competition: a reviewJaume Puig-Junoy
Health Policy (Amsterdam, Netherlands)|January 15, 2004
Incentives and pharmaceutical reimbursement reforms in SpainJaume Puig-Junoy
Gaceta Sanitaria|October 6, 2007
[Comment. Substitution at pharmacies and generic market]Jaume Puig-Junoy
Gaceta Sanitaria|February 20, 2007
[The financing and price regulation of drugs in the Spanish National Health System: changes and continuity]Jaume Puig-Junoy
Health Policy (Amsterdam, Netherlands)|March 21, 2007
The impact of generic reference pricing interventions in the statin marketJaume Puig-Junoy
Revista De Enfermeria (Barcelona, Spain)|September 16, 2004
[Treatment and capitation integration]Jaume Puig Junoy
Gaceta Sanitaria|March 17, 2006
[Health care financing: is it enough and appropriate?]Jaume Puig-Junoy
Gaceta Sanitaria|March 2, 2010
[Policies encouraging price competition in the generic drug market: Lessons from the European experience]Jaume Puig-Junoy
Applied Health Economics and Health Policy|August 21, 2012
Do higher-priced generic medicines enjoy a competitive advantage under reference pricing?Jaume Puig-Junoy
Applied Health Economics and Health Policy|September 16, 2005
What is required to evaluate the impact of pharmaceutical reference pricing?Jaume Puig-Junoy
Pageof 7